These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38756153)

  • 21. A Systematic Analysis of COVID-19 Clinical Trials Registered in the Clinical Trials Registry of India.
    Dutta S; Singhal S; Shah R
    Cureus; 2024 Apr; 16(4):e57939. PubMed ID: 38738059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do clinical trials conducted in India match its healthcare needs? An audit of the Clinical Trials Registry of India.
    Chaturvedi M; Gogtay NJ; Thatte UM
    Perspect Clin Res; 2017; 8(4):172-175. PubMed ID: 29109934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials.
    Chihara D; Lin R; Flowers CR; Finnigan SR; Cordes LM; Fukuda Y; Huang EP; Rubinstein LV; Nastoupil LJ; Ivy SP; Doroshow JH; Takebe N
    Lancet; 2022 Aug; 400(10351):512-521. PubMed ID: 35964611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An analysis of deficiencies in the data of interventional drug trials registered with Clinical Trials Registry - India.
    Pillamarapu M; Mohan A; Saberwal G
    Trials; 2019 Aug; 20(1):535. PubMed ID: 31455366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Clinical Trials Registry-India, the classification of sponsors needs to be standardised.
    Mendiratta J; Pillamarapu M; Saberwal G
    Indian J Med Ethics; 2024; IX(1):11-18. PubMed ID: 38375647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of
    Adhikari T; Rao MVV; Srikanth N; Juneja A; Sharma S; Maulik M; Gupta J; Panchal Y; Rao BCS; Khanduri S; Narayan RV; Bhardwaj R; Batra P
    Ayu; 2020; 41(3):143-147. PubMed ID: 35370375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stroke incidence, mortality, subtypes in rural and urban populations in five geographic areas of India (2018-2019): results from the National Stroke Registry Programme.
    Rangamani S; Huliyappa D; Kulothungan V; Saravanan S; Murugan PK; Mahadevan R; Rachel Packiaseeli C; Bobby E; Sunitha K; Mallick AK; Nayak SD; Swain SK; Behera M; Nath BK; Swami A; Kalwar AK; Difoesa B; Sardana V; Maheshwari D; Bhushan B; Mittal D; Chaurasia RN; Meena LP; Vinay Urs KS; Koli RR; Suresh Kumar N; Mathur P
    Lancet Reg Health Southeast Asia; 2024 Apr; 23():100308. PubMed ID: 38404513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burden of cancers in India - estimates of cancer crude incidence, YLLs, YLDs and DALYs for 2021 and 2025 based on National Cancer Registry Program.
    Kulothungan V; Sathishkumar K; Leburu S; Ramamoorthy T; Stephen S; Basavarajappa D; Tomy N; Mohan R; Menon GR; Mathur P
    BMC Cancer; 2022 May; 22(1):527. PubMed ID: 35546232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic clinical trials to combat COVID-19 pandemic in India: analysis from trial registry.
    Batta A; Khirasaria R; Kapoor V; Varshney D
    J Basic Clin Physiol Pharmacol; 2020 Dec; 32(3):267-278. PubMed ID: 33578506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review of clinical studies involving pregnant women registered in the Clinical Trials Registry of India.
    Karekar SR; Pooja SG; Marathe PA
    Perspect Clin Res; 2020; 11(1):8-12. PubMed ID: 32154143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hidden duplicates: 10s or 100s of Indian trials, registered with ClinicalTrials.gov, have not been registered in India, as required by law.
    Kumari S; Mohan A; Saberwal G
    PLoS One; 2020; 15(6):e0234925. PubMed ID: 32559240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CTRI - Clicking to greater transparency and accountability.
    George B
    Perspect Clin Res; 2012 Oct; 3(4):122-4. PubMed ID: 23293758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A critical appraisal of clinical trials conducted and subsequent drug approvals in India and South Africa.
    Limaye D; Langer JM; Rühling T; Fortwengel G
    BMJ Open; 2015 Aug; 5(8):e007304. PubMed ID: 26324720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of competence training for the minimally trained health worker in type 2 diabetes: A cluster randomized controlled trial.
    Gudlavalleti AG; Babu GR; van Schayck OCP; Schaper NC; Lewis MG; Murthy GVS
    Medicine (Baltimore); 2020 Oct; 99(44):e22959. PubMed ID: 33126364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Snapshot of COVID-19 Related Clinical Trials in India.
    Charan J; Kaur R; Bhardwaj P; Kanchan T; Mitra P; Yadav D; Sharma P; Misra S
    Indian J Clin Biochem; 2020 Oct; 35(4):418-422. PubMed ID: 32837035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Geographic disparities in access to cancer clinical trials in India.
    Chakraborty S; Mallick I; Luu HN; Bhattacharyya T; Arunsingh M; Achari RB; Chatterjee S
    Ecancermedicalscience; 2021; 15():1161. PubMed ID: 33680075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of clinical trials registered in India from 2008 to 2022 to describe the first-in-human trials.
    Sabu ST; Venkatraman S; Cherian JJ; Das S; Pahuja M; Adhikari T; Mukherjee S; Chatterjee NS; Kshirsagar NA
    Perspect Clin Res; 2024; 15(1):18-23. PubMed ID: 38282636
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.